Early Treatment and HIV-1 Reservoirs: A Stitch in Time?

Por Henrich, Timothy J., Gandhi, Rajesh T.
Publicado em 2013

HIV-1 Entry Inhibitors: Recent Development and Clinical Use

Por Henrich, Timothy J., Kuritzkes, Daniel R.
Publicado em 2013

Instantaneous Inhibitory Potential is Similar to Inhibitory Quotient at Predicting HIV-1 Response to Antiretroviral Therapy

Por Henrich, Timothy J., Ribaudo, Heather, Kuritzkes, Daniel R.
Publicado em 2010

Clinical Risk Factors for Severe Clostridium difficile–associated Disease

Por Henrich, Timothy J., Krakower, Douglas, Bitton, Asaf, Yokoe, Deborah S.
Publicado em 2009

Increased Risk of Virologic Rebound in Patients on Antiviral Therapy with a Detectable HIV Load <48 Copies/mL

Por Henrich, Timothy J., Wood, Brian R., Kuritzkes, Daniel R.
Publicado em 2012

Low-Level Detection and Quantitation of Cellular HIV-1 DNA and 2-LTR Circles Using Droplet Digital PCR

Por Henrich, Timothy J., Gallien, Sebastien, Li, Jonathan Z., Pereyra, Florencia, Kuritzkes, Daniel R.
Publicado em 2012

Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1

Por Rosenbloom, Daniel I. S., Elliott, Oliver, Hill, Alison L., Henrich, Timothy J., Siliciano, Janet M., Siliciano, Robert F.
Publicado no Open Forum Infect Dis (2015)

Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV

Por Hill, Alison L., Rosenbloom, Daniel I. S., Goldstein, Edward, Hanhauser, Emily, Kuritzkes, Daniel R., Siliciano, Robert F., Henrich, Timothy J.
Publicado no PLoS Pathog (2016)

Advances in biosensing strategies for HIV detection, diagnosis, and therapeutic monitoring

Por Lifson, Mark A., Ozen, Mehmet Ozgun, Inci, Fatih, Wang, ShuQi, Inan, Hakan, Baday, Murat, Henrich, Timothy J., Demirci, Utkan
Publicado no Adv Drug Deliv Rev (2016)

Evolution of CCR5 Antagonist Resistance in an HIV-1 Subtype C Clinical Isolate

Por Henrich, Timothy J., Tsibris, Athe M.N., Lewine, Nicolas R.P., Konstantinidis, Ioannis, Leopold, Kay E., Sagar, Manish, Kuritzkes, Daniel R.
Publicado em 2010

Nanostructured Optical Photonic Crystal Biosensor for HIV Viral Load Measurement

Por Shafiee, Hadi, Lidstone, Erich A., Jahangir, Muntasir, Inci, Fatih, Hanhauser, Emily, Henrich, Timothy J., Kuritzkes, Daniel R., Cunningham, Brian T., Demirci, Utkan
Publicado em 2014

CCR5-Δ32 Heterozygosity, HIV-1 Reservoir Size, and Lymphocyte Activation in Individuals Receiving Long-term Suppressive Antiretroviral Therapy

Por Henrich, Timothy J., Hanhauser, Emily, Harrison, Linda J., Palmer, Christine D., Romero-Tejeda, Marisol, Jost, Stephanie, Bosch, Ronald J., Kuritzkes, Daniel R.
Publicado no J Infect Dis (2016)

Viremic Control and Viral Coreceptor Usage in Two HIV-1-Infected Persons Homozygous for CCR5 Δ32

Por Henrich, Timothy J., Hanhauser, Emily, Hu, Zixin, Stellbrink, Hans-Jürgen, Noah, Christian, Martin, Jeffrey N., Deeks, Steven G., Kuritzkes, Daniel R., Pereyra, Florencia
Publicado no AIDS (2015)

HIV-1 Clinical Isolates Resistant to CCR5 Antagonists Exhibit Delayed Entry Kinetics That Are Corrected in the Presence of Drug

Por Putcharoen, Opass, Lee, Sun Hee, Henrich, Timothy J., Hu, Zixin, Vanichanan, Jakapat, Coakley, Eoin, Greaves, Wayne, Gulick, Roy M., Kuritzkes, Daniel R., Tsibris, Athe M. N.
Publicado em 2012

Printed Flexible Plastic Microchip for Viral Load Measurement through Quantitative Detection of Viruses in Plasma and Saliva

Por Shafiee, Hadi, Kanakasabapathy, Manoj Kumar, Juillard, Franceline, Keser, Mert, Sadasivam, Magesh, Yuksekkaya, Mehmet, Hanhauser, Emily, Henrich, Timothy J., Kuritzkes, Daniel R., Kaye, Kenneth M., Demirci, Utkan
Publicado no Sci Rep (2015)

Differential Use of CCR5 by HIV-1 Clinical Isolates Resistant to Small-Molecule CCR5 Antagonists

Por Henrich, Timothy J., Lewine, Nicolas R. P., Lee, Sun-Hee, Rao, Suhas S. P., Berro, Reem, Gulick, Roy M., Moore, John P., Tsibris, Athe M. N., Kuritzkes, Daniel R.
Publicado em 2012

SHIV-162P3 Infection of Rhesus Macaques Given Maraviroc Gel Vaginally Does Not Involve Resistant Viruses

Por Tsibris, Athe M. N., Pal, Urboshi, Schure, Allison L., Veazey, Ronald S., Kunstman, Kevin J., Henrich, Timothy J., Klasse, P. J., Wolinsky, Steven M., Kuritzkes, Daniel R., Moore, John P.
Publicado em 2011

Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study

Por Henrich, Timothy J., McLaren, Paul J., Rao, Suhas S. P., Lin, Nina H., Hanhauser, Emily, Giguel, Francoise, Gulick, Roy M., Ribaudo, Heather, de Bakker, Paul I. W., Kuritzkes, Daniel R.
Publicado no Open Forum Infect Dis (2014)

XMRV Prevalence in Patients with Chronic Fatigue Syndrome or Chronic Immunomodulatory Conditions

Por Henrich, Timothy J., Li, Jonathan Z., Felsenstein, Donna, Kotton, Camille N., Plenge, Robert M., Pereyra, Florencia, Marty, Francisco M., Lin, Nina H., Grazioso, Paul, Crochiere, Danielle M., Eggers, Daniel, Kuritzkes, Daniel R., Tsibris, Athe M. N.
Publicado em 2010

HIV-1 persistence in CD4(+) T cells with stem cell-like properties

Por Buzon, Maria J., Sun, Hong, Li, Chun, Shaw, Amy, Seiss, Katherine, Ouyang, Zhengyu, Martin-Gayo, Enrique, Leng, Jin, Henrich, Timothy J., Li, Jonathan Z., Pereyra, Florencia, Zurakowski, Ryan, Walker, Bruce D., Rosenberg, Eric S., Yu, Xu G., Lichterfeld, Mathias
Publicado em 2014